Inventor
JINFA DU
Inventor
CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds19%
C07HSugars12%
C07BGeneral methods of organic chemistry8%
Y02ATechnologies for adaptation to climate change8%
C07CAcyclic or carbocyclic compounds4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
12,428,3982-(2,4,5-substituted phenylamino) pyrimidine derivative and crystalline form B thereof202512,297,224Crystal form, preparation method, and application of 4'-substituted nucleoside202512,161,625Substituted pyrrolizine compounds and uses thereof202412,121,529Nucleoside phosphoramidate prodrugs202411,642,361Nucleoside phosphoramidate prodrugs202311,578,049Benzoic acid compound and method for preparing the same2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to GILEAD SCIENCES INC (3)· patent assignee history
2023–2025Patents assigned to HENAN GENUINE BIOTECH CO LTD (3)· patent assignee history
2023–2025Based in CN· patent location history
2023–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 3 | 2023–2024 |
| HENAN GENUINE BIOTECH CO LTD | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 3 | 2023–2025 |
| US | 3 | 2023–2024 |